Home About Us Leadership Mori J. Krantz, MD - Peer Reviewed Journal Articles

Mori J. Krantz, MD - Peer Reviewed Journal Articles

Peer Reviewed Journal Articles:

  1. Leeman-Castillo B, Westfall JM, Corbett KK, Dreisbach SL, Krantz MJ.  Treatment Seeking Delay among Latina and non-Latina Women with Acute Myocardial Infarction (under review).
  2. Sheridan S, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters K, Kopin L, Lungelow D Does giving adults global coronary risk information improve health outcomes? A systematic evidence review (in press Archives Int Med).
  3. Estacio RO, Krantz MJ, Coll J, Dale R, Schrier RS. Microalbuminuria predicts 10-year cardiac death in diabetes: analysis of the ABCD trial. (presented AHA, manuscript submitted Circ)
  4. Lee J, Krantz MJ. An aversion to food: marked deglutition syncope (in press Clin Cardiol).
  5. Amburdekar A, Fonarow GC, Cannon C, Dai D, Hernandez A, Krantz MJ. Quality of Cardiovascular Care and In-Hospital Outcomes for Rural and Urban Hospitals: Findings from Get With The Guidelines-Coronary Artery Disease Program. (in press Am J Cardiol).
  6. Amburdekar A, Krantz MJ. Flip flop heart. (in press Mayo Clin Proc)
  7. Krantz MJ, Berger JS, Hiatt WR. An aspirin a day: are we barking up the wrong willow tree? In press Pharmacotherapy
  8. Jensen LJ, Leeman-Castillo B, Coronel SM, Perry D, Belz C, Kapral C, Krantz MJ. Impact of a nurse telephone intervention among high cardiovascular risk health fair participants.  Journal of Cardiovascular Nursing 2009;24:447-453.
  9. Amburdekar A, Fonnarow GC, Krantz MJ. Characteristics and In-Hospital Outcomes for Nonadherent Patients with Heart Failure: Findings from Get With The Guidelines-Heart Failure Am Heart J 2009;158:644-52
  10. Kittelson, JM, Krantz MJ, Hiatt WR.. Aspirin for the Prevention of Cardiovascular Events in Patients with Peripheral Artery Disease. JAMA 2009;302(11):1165-1166.
  11. Mehler PS, Sabel A, Trantanella A, Krantz MJ. Variation in prehospital and discharge quality of care among acute myocardial infarction patients at a safety net hospital. Crit Pathw Cardiol 2009;8(3): 127-130.
  12. Krantz MJ, Martin J, Stimmel B, Haigney MCP. Concerns about consensus guidelines for QTc interval screening in methadone treatment. Ann Int Med 2009; 151(3):218-219.
  13. Berger J, Krantz MJ, Kittelson J, Hiatt WR. Aspirin for the Prevention of Cardiovascular Events in Patients with Peripheral Artery Disease: A Meta-Analysis of Randomized Trials. JAMA 2009;301(18):1909-1919.
  14. Andrews CM, Krantz MJ, Wedam E, Marcuson M, Capacchione J, Haigney MC. Methadone-induced Mortality in the Treatment of Chronic Pain: Role of QT Prolongation Cardiol J. 2009;16(3):210-7.
  15. Amburdekar A, Krantz MJ The Brugada Syndrome: The Perfect Storm of Genetics and Environment? Int J Cardiol  2009 Jan 19. [Epub ahead of print].
  16. Schmittner JS, Schroeder JR, Bleiberg J, Krantz MJ, Eied N, Preston KL. Electrocardiographic Effects of Lofexidine and Methadone coadministration: secondary findings from a safety study. Pharmacotherapy 2009;29(5):495-502.
  17. Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MCP. QTc interval screening and methadone treatment. Ann Intern Med 2009;150(6):387-95.
  18. Krantz MJ. Heterogeneous impact of Methadone on the QTc Interval: what are the practical implications? J Addict Diseases 2008;27(4):5-9.
  19. Krantz MJ, Tanner J, Horwitch T, Hernandez A, Dai D, Albert N, Yancy C, Fonnarow GC. Influence of Hospital Length of Stay for Heart Failure on Quality of Care Am J Cardiol 2008;102:1693–1697.
  20. Havranek EA, Froshaug DB, Emserman CDB, Hanratty R, Krantz MJ, Masoudi FA, Dickinson LM, Steiner JF.  Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med 2008;121:870-875.
  21. Amburdekar A, Krantz MJ. The Crypts and The Blood: a case of isolated left ventricular noncompaction. Mayo Clin Proc 2008;83(8):866.
  22. Baker WA, Krantz MJ. QTc interval prolongation and opioid addiction therapy. Arch Intern Med 2008;168(14):1592.
  23. Smith CS, Harbrejct M, Krantz MJ. A State Consensus Guideline for the Prevention of Cardiovascular Disease in Primary Care Settings Crit Pathways Cardiol 2008;7(2):122-5.
  24. Krantz MJ, Havranek E, Haynes D, Smith I, Bucher-Bartelson B, Long CL. Effects of carvedilol on health outcomes in vulnerable heart failure patients: a randomized trial. J Card Fail. 2008;14:303-9.
  25. Eng MH, Krantz MJ. Evaluation and management of chest Pain. BMJ 2008 on line.
  26. Dale R, Jensen L, Krantz MJ. A comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother 2008;42(5):633-9 [Epub 2008 Apr 15].
  27. Havranek EA, Havranek EP, Emsermann CD, Froshaug DN, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO, Dickinson LM, Steiner JF. Thresholds in the relationship between mortality and left ventricular hypertrophy defined by electrocardiography. J Electrocardiol. 2008;41:342-350.
  28. Amburdekar A, Lewkowiez L, Krantz MJ. Mastitis unmasks Brugada Syndrome. Int J Cardiol Int J Cardiol (2007), doi:10.1016/j.ijcard.2007.07.154 [Epub ahead of press].
  29. Batal H, Krantz MJ, Mehler PS, Dale R, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Serv Res. 2007;25;7(1):175 [Epub ahead of print]
  30. Krantz MJ, Rowan S, Schmittner J, Bucher-Bartelson B. Physician awareness of methadone’s cardiac effects: a national survey. J Addict Diseases 2007;26(4):79-85.
  31. Burgess, FW, Krantz MJ, Barkin RL. Methadone: unintended mortality due to overdose and arrhythmia. Pain Medicine News, 2007 May/June 1-4.
  32. Bartecchi C, Krantz MJ, Bucher Bartelson B, et al. Response to Letter. Reduction in myocardial infarction with a city wide smoking ordinance. Circulation 2007;115:e425.
  33. Krantz MJ, Estacio R, Mehler PS, Fonarow GC Baker WA, Long CS. Comprehensive coronary artery disease care in a safety-net hospital: Results of Get With The Guidelines quality improvement initiative. J Manag Care Pharm 2007;13(4):319-25.
  34. Eng MH, Garcia JA, Hangsen A, Krantz MJ. Impending Left Ventricular Rupture.
    Clin Cardiol. 2007 Jun 13; [Epub ahead of print]
  35. Schroeder JR, Schmittner JS, Bleiberg J, Epstein DH, Krantz MJ, Preston KL. Hemodynamic and cognitive effects of methadone and lofexidine coadministration: a pilot study. Pharmacotherapy 2007;27(8):1111-1119.
  36. Hiatt WR, Krantz MJ. The efficacy of aspirin in peripheral arterial disease: an unresolved question. J Mal Vasc 2007;32:71-2.
  37. Bruintjes G, Krantz MJ. Acute vs. chronic second hand smoke exposure and acute myocardial infarction. Arch Int Med 2007;167(7):731.
  38. Krantz MJ, Mehler PS. Methadone and QTc prolongation.  Lancet 2007;369:366-7.
  39. Coronel SM, Krantz MJ. Medical therapy for symptomatic heart failure: a contemporary treatment algorithm. Crit Pathways in Cardiol 2007;6:15-17.
  40. Schmittner JS, Krantz MJ. Methadone and QTc prolongation: fact and fiction. Heroin Addict Relat Clin Probl 2006;8(4):41-52.
  41. Krantz MJ, Schmittner JS. Pleiotropic effects of statins: clinical paradigm or research fiction? Pharmacotherapy 2006;26(11):e129-e130.
  42. Schmittner JS, Krantz MJ. QTc prolongation among hospitalized patients receiving methadone. Arch Int Med 2006;166(20):2289.
  43. Krantz MJ, Baker WA, Schmittner JS. Cocaine and Methadone: parallel effects on the QTc interval Am J Cardiol 2006;98(8):1121.
  44. Bartecchi C, Alsever RN, Nevin-Woods C, Thomas WH, Estacio RO, Bucher Bartelson B, Krantz MJ. Reduction in the incidince of acute myocardial infarction associated with a citywide smoking ordinance. Circulation 2006;114:1490-6.
  45. Krantz MJ, Mehler PS. QTc prolongation: methadone’s efficacy-safety paradox. Lancet 2006;368:356-7.
  46. Krantz MJ. Implications of thiazolodinedione use and cardiovascular risk: is it all about the blood sugar? Pharmacotherapy 2006;26(7): 1049-50.
  47. Hiatt WR, Krantz MJ. Antiplatelet therapy in peripheral arterial disease and claudication Vascular Medicine 2006;11:1-6.
  48. Rowan S, Krantz MJ. Paradoxical decrease in blood pressure after relief of cardiac tamponade: the role of sympathetic activity. Med Sci Monit. 2006;12(2):CS16-19.
  49. Krantz MJ, Mehler PS. Heart rate variability in women. Arch Int Med 2006;166:247.
  50. Schmittner JS, Krantz MJ. High-dose methadone and QTc prolongation: strategies to optimize safety. Journal of Opioid Management 2006:2(1):49-55.
  51. Mehler PS, Krantz MJ, Lundgren RA, Estacio RO, MacKenzie TP, Petralia L, Hiatt WR. Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention. Am J Med 2005;118(12):1414.e13-1414.e19.
  52. Krantz MJ, Coronel S, Hiatt WR. Use of ankle brachial index screening for selecting patients for antiplatelet therapy. Pharmacotherapy 2005;25(12)1826-28.
  53. Krantz MJ. Expanding criteria for transient left ventricular apical ballooning syndrome. [letter] Ann Int Med January 6 2005. Available at: www.annals.org/letters/141/11/858.
  54. Mehler PS, Krantz MJ. QT dispersion in anorexia nervosa. Am J Cardiol 2005;96(7):1034.
  55. Mehler PS, Krantz MJ. Bulimia-Medical Complications. Synapse 2005;217:42-47.
  56. Krantz MJ, Coronel SM, Leeman-Castillo, et al. Lipid-modifying therapy in high-risk patients. Drug Benefit Trends. 2005;17(suppl E):8-16..
  57. Krantz MJ, Lowery CM, Martell BA, Gouerevitch MN, Arnsten JH. Effects of methadone on QT interval dispersion. Pharmacotherapy 2005;25(11):1523-29.
  58. Krantz MJ, Haugen SJ, Batal HA, Long CS. Off-site percutaneous intervention reduces hospital length of stay in vulnerable patients with acute myocardial infarction. Crit Pathways in Cardiol 2005:4(3):127-130.
  59. Krantz MJ, Garcia JA. Pseudo-torsade de pointes with underlying wandering atrial pacemaker Clin Cardiol 2005;28:355.
  60. Hyde JK, Krantz MJ, Woods JE. Intracardiac mass in a man infected with human immunodeficiency virus. Arch Pathol Lab Med 2005;129(7):943-4.
  61. Krantz MJ, Zwang O, Rowan S, et al. A cooperative care model: cardiologists and Hospitalists reduce length of stay in a chest pain observation unit. Crit Pathways in Cardiol 2005;4:55-58.
  62. Krantz MJ, Lee D, Donahoo WT, Mehler PS. The paradox of normal serum albumin in anorexia nervosa. Int J Eat Disord 2005;37:278-80.
  63. Martell BA, Arnsten JH, Krantz MJ, Goerevitch MN. Impact of oral methadone on cardiac repolarization and conduction in opioid users Am J Cardiol 2005;95(7):915-8.
  64. Krantz MJ, Garcia JA, Mehler PS. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes. Pharmacotherapy 2005;25:611-14.
  65. Krantz MJ, Estacio RO, Mehler PS. Angiotensin Converting Enzyme Inhibitors and myocardial infarction: a class effect? Am J Cardiol 2005;95(7):924.
  66. Garcia J, Krantz MJ, Baker WA. Two cases of rhythm disturbance. Consultant 2005;45(3)327-330.
  67. Krantz MJ, Garcia JA, Mehler PS. Tramadol-associated pericarditis. Int J Cardiol 2005;99:497-8.
  68. Krantz MJ, Rowan SB, Mehler PS. Cocaine-related torsade de pointes in a methadone maintenance patient. J Addict Dis 2005;24(1):53-60.
  69. Krantz MJ, Donahoo WT, Melanson EL, Mehler PS. QT interval dispersion and resting metabolic rate in chronic anorexia nervosa. Int J Eat Disord 2005;37:166-170.
  70. Krantz MJ, Lowery CM. Giant Osborn waves in hypothermia N Engl J Med 2005:352(2):184.
  71. Krantz MJ. Angiotensin-Converting Enzyme Inhibitors and stroke: blood pressure reduction is major determinant of risk. Pharmacotherapy 2004;24(12):1813-14.
  72. Center for Substance Abuse Treatment. Methadone-Associated Mortality: Report of a National Assessment. DHHS Publication No. (SMA) 04-3904. Rockville, MD: Center for Substance Abuse and Mental Health Services Administration, 2004. Available at: www.samhsa.gov
  73. Krantz MJ, Philip S. Mehler. Angiotensin-Converting inhibitors and diuretics: optimal combination therapy. Ann Intern Med 2004;141(11):893.
  74. Melanson EL, Donahoo WT, Krantz MJ, Poirier P, Mehler PS. Resting and ambulatory heart rate variability in chronic anorexia nervosa. Am J Cardiol 2004;94:1217-20.
  75. Krantz MJ, Mehler PS. Treating Opioid Dependence: Growing Implications for Primary Care. Arch Int Med 2004;164:277-88.
  76. Krantz MJ, Watson K, Leeman-Castillo BA, Mehler PS. Coronary heart disease care in older women: optimizing diagnosis and therapy. JAMWA 2004;59:286-294.
  77. Krantz MJ, Garcia J.  Dyslipidemia in high-risk patients. A rational approach to therapy. Consultant 2004;44(10):1321-1328.
  78. Garcia J, Krantz MJ, Baker WA.  ECG challenge: Two cases of ST-segment elevation. Consultant 2004;44(10):1343-1346.
  79. Krantz MJ, Lee JK, Spodick DH. Repetitive yawning associated with acute pericardial tamponade. Am J Cardiol 2004;94(5):701-2
  80. Krantz MJ, Mehler PS. Resting tachycardia, a warning sign in anorexia nervosa. BMC Cardiovasc Disord 2004:4:10.
  81. Krantz MJ, Havranek EP, Mehler PS, Haynes DK, Long CS. Impact of a cardiac risk reduction program in vulnerable patients hospitalized with coronary artery disease. Pharmacotherapy 2004;24(6):768-775.
  82. Krantz MJ, Garcia JA. Metabolic disturbances: What the ECG shows. Consultant 2004;44(6):803-8.
  83. Krantz MJ. Cardiovascular effects of ephedra.  JAMA 2004;291:1560.
  84. Krantz, MJ Blood pressure control in type 2 diabetes mellitus. Ann Intern Med 2004;140:487.
  85. Krantz MJ, Mehler PS. Methadone and QT-prolongation: a dose-dependent effect? Am J Cardiol 2004;93:952.
  86. Krantz MJ, Mehler PS.  Synthetic Opioids and QT Prolongation. Arch Intern Med 2003;163:1615.
  87. Krantz MJ. Angiotensin Conveting Enzyme Inhibitors: Optimal management of cardiovascular risk. Am J Cardiol 2003;92(7):900.
  88. Leavitt S, Krantz MJ. Cardiac considerations in methadone maintenance treatment (MMT). Special Report. AT Forum 2003. Available at: www.atforum.com.
  89. Krantz MJ, Martell B, Arnsten JH, Goerevitch MN. Medications that prolong the QT interval. JAMA 2003;290(8):1025.
  90. Krantz MJ, Baker WA. Non-invasive evaluation of ischemic heart disease. Consultant 2003;43(1):23-32.
  91. Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. Pharmacotherapy 2003;23(6):802-805.
  92. Mehler PS, Krantz MJ. Anorexia nervosa Medical issues. J Women’s Health 2003;12(4):331-340.
  93. Krantz MJ, Mehler PS. Case in point: Cardiac complications in anorexia nervosa. Consultant 2003;43(9):1095-7.
  94. Krantz MJ. Secondary prevention of coronary artery disease: Combining the evidence. Primary Care Case Reviews 2003;6(3)110-20.
  95. Baker WA, Krantz MJ. Aortic Stenosis in the adult.  Primary Care Case Reviews 2003;6(4):162-9.
  96. Krantz MJ, Lewkowiez L, Hays H, et al. Torsade de pointes associated with very high-dose methadone. Ann Intern Med. 2002;137:501-4.
  97. Leavitt S, Krantz MJ, Ling W, Payte TJ, Tenore PL, Stimmel B, Casodonte PP, Kipnis S, Vossi F. Expert Panel Clinical Guidelines on LAAM In Opioid Agonist Therapy (OAT). Technical Assistance Publication (TAP) Series. U.S. Department of Health and Human Services.  Rockville, MD 20857, 2002.
  98. Krantz MJ, Dart RC, Mehler PS. Transient pulmonary infiltrates possibly induced by quinine sulfate. Pharmacotherapy 2002;22:775-8.
  99. Krantz MJ. A practical approach to cardiac stress testing. Primary care case reviews 2002;5:26-33.
  100. Krantz MJ, Baker WA. ECG challenge. Consultant 2002;42:501-516.
  101. Krantz MJ, Llewellyn A, Moreo K. Reducing vascular events in patients with diabetes. Case Management Society of America, CMSA, 2002. Available at: www.cmsa.org.
  102. Krantz MJ, Baker WA. ECG challenge: Test your interpretative skills. Consultant 2002;42:1757-68.
  103. Krantz MJ, Woods JA, Havranek EP, Linas S. Simultaneous Malignant hypertension and Cardiac Tamponade. Am J Kidney Dis 2002;39:E17, 1-5.
  104. Krantz MJ, Llewellyn A, Moreo K.  Case Management resource path for reducing vascular events in patients with diabetes. Case Management Society of America, CMSA, 2002. Available at: www.cmsa.org
  105. Krantz, MJ. Clinical Concepts: Cardiac Health in MMT Patients, AT Forum 2001;10(4):1-5.
  106. Krantz, MJ, Baker WA, Long CS. Secondary MI Prevention: Which drugs are essential?
    Consultant 2001;41:1377-1385
  107. Colizzo F, Hastie AT, Krantz MJ. Investigation of respiratory epithelial surface and ciliary axoneme protein changes after formaldehyde exposure.  J Toxic Environ Health 1992;35:221-34.
  108. Hastie AT, Colizzo F, Evans L, Krantz MJ, Fish J.  Initial characterization of tektins in cilia of respiratory epithelial cells.  Chest 1992;101: 47S-48S.
  109. Hastie AT, Krantz MJ, Colizo F.  Identification of surface components of mammalian respiratory cilia.  Cell Motility and the Cytoskeleton 1990;17: 317-28.

Published Abstracts:
  1. Patrick H, Gray JW, Krantz MJ, Shepley KS. Serum Angiotensin Converting Enzyme (ACE) Heterogeneity: Differences in Specific Activity. FASEB Journal 1988;2: A551.
  2. Hastie AT, Krantz MJ. Lectin Binding to Bovine Respiratory Ciliary Proteins. J. Cell Biology 1988;107: 21A.
  3. Hastie AT, Krantz MJ, Fish J. Ultrastructural Alterations to Ciliated Respiratory Epithelium Upon Exposure to Toluene Diisocyanate. Amer Rev Resp Dis 1989;139: A388.
  4. Krantz MJ, Haugen SJ. Off-site percutaneous intervention reduces hospital length of stay in vulnerable patients with acute myocardial infarction. AHA 4th Scientific Forum on Quality of Care and Outcomes Research in CVD and Stroke. Washington DC, October 13 2002. Circulation 2002;106:e76.
  5. Krantz MJ, Haugen SJ, Haynes DK. Effects of a cardiac risk reduction program in vulnerable patients with coronary artery disease. AHA 4th Scientific Forum on Quality of Care and Outcomes Research in CVD and Stroke. Washington DC, October 13 2002. Circulation 2002;106:e76.
  6. Krantz MJ, Haynes D, Aller K, Baker W, Long CS. Improvement in acute myocardial infarction treatment by implementation of “Get With The Guidelines” at a safety net hospital. 73d AHA Scientific Session. Orlando FL, November 11 2003.
  7. Krantz MJ, Lowery CM, Martell BA, Gourevitch MN, Arnsten JH. Effects of oral methadone on QT interval dispersion in opioid-dependent patients. 6th International Conference on Pain and Chemical Dependency. Brooklyn NY, February 5 2004.
  8. Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN. Impact of methadone on cardiac repolarization and conduction in opioid users. 27th Society of General Internal Medicine (SGIM) Annual Meeting. New Orleans LA, May 15 2004; # 115665.
  9. Krantz MJ, Esler AL, Lowery CM, Long CS, Haynes DK, Estacio RO. Secular trends in guideline-based care in vulnerable patients hospitalized with coronary artery disease. AHA 5th Scientific Forum on Quality of Care and Outcomes Research in CVD and Stroke. Washington DC, May 15th 2004 [abstract P187] Available at: http://www.americanheart.org/presenter.jhtml?identifier=3021852
  10. Krantz MJ, Zwang O, Rowan S, Statland B, Reid M, Chu E. A cooperative care model: cardiologists and Hospitalists reduce length of stay in a chest pain observation unit. AHA 5th Scientific Forum on Quality of Care and Outcomes Research in CVD and Stroke. Washington DC, May 15th 2004. [abstract P186]. Available at: http://www.americanheart.org/presenter.jhtml?identifier=3021852
  11. Zwang O, Krantz MJ, Rowan S, Statland B, Reid M, Chu E, Albert R. Hospitalists decrease length of stay in a chest pain observation unit: a pilot study. American Hospitalist Association Meeting, April 19th 2004, New Orleans LA.
  12. Bartechi C, Alsever RN, Nevin-Woods C, Estacio RO, Tran ZV, Krantz MJ. A citywide smoking ordinance reduces the incidence of myocardial infarction . AHA Scientific Sessions 2005, Dallas TX.
  13. Krantz MJ, Havranek EP, Haynes D, Smith I, Long CS. Inpatient initiation of beta blocker reduces hospitalization among vulnerable heart failure patients. AHA Scientific Sessions 2005, Dallas TX.
  14. Havranek EP, Bublitz C, Masoudi FA, Krantz MJ, Hanratty R, Estacio RO et al. ECG threshold for left ventricular hypertrophy and mortality in NHANES III. ACC Annual Scientific Sessions 2006, Atlanta GA
  15. Leeman-Castillo B, Westfall J, Korbitt K, Krantz MJ. Treatment seeking behavior in Latina AMI patients, May 6th 2006, AHA Quality Outcome Forum.
  16. Krantz MJ, Coronel SA, Mackenzie TM. Gender differences in CVD risk perceptions. Colorado Public Health Association meeting, 2006.
  17. Mackenzie TD, Coronel SM, Leeman-Castillo B, Bartelson BB, Jensen L, Kapral C, Estacio R, Krantz MJ. An interactive computerized cardiac risk module highlights misperceptions and under-treatment of risk factors among health fair Participants. Society of General Internal Medicine Annual Meeting, Tororonto Canada, April 2007.
  18. Smith C, Coronel S, Bucher-Bartelson B, Krantz MJ. Evidence-based Approaches to Cardiovascular Disease Prevention in Colorado, Colorado Public Health Conference, Fort Collins Colorado. September 17th 2007.
  19. Estacio R, Schrier R, Krantz MJ, Coll J, et al. Urinary microalbuminuria predicts CHD mortality in diabetic hypertensive patients: 10-year follow up of ABCD trial. AHA, November 2007
  20. Kapral C, Krantz MJ. CVD risk factor knowledge among monolingual Latinos. Colorado Public Health Conference, Colorado. September 2008.
  21. Coronel S, Bruntjes G, Krantz MJ. Minimal prevalence of metabolic syndrome among 80,000 health fair participants. Colorado Public Health Conference, Colorado. September 2008.
  22. Bruntjes G, Coronel S, Estacio R, Bucher Bartelson B, Krantz MJ. Impact of a public smoking ordinance on AMI rates in Greeley CO. Colorado Public Health Conference, Colorado. September 2008.
  23. Carlin S. Long, Mori J. Krantz, Raymond O. Estacio, L. Miriam Dickinson, David Coyle, Frederick A. Masoudi, Christine Neuman, Inez Smith, Elhum Karimkhani, Edward P. Havranek. LpPLA2, Not hsCRP provides improved risk discrimination among a cohort of hypertensive Latinos in a Safety-Net Institution. American Society of Hypertension, 24th Scientific Meeting. San Francisco, CA. May 6th 2009. P-120 Translation track.
  24. Mori J. Krantz, Carlin S. Long, Raymond O. Estacio, Kathryn L. Benton, Elhum Karimkhani, Miriam Dickinson, Frederick A. Masoudi, David Coyle, Edward P. Havranek. Pulse Wave Velocity Predicts Pre-Clinical Atherosclerosis among Latino Patients with Chronic Hypertension. American Society of Hypertension, 24th Scientific Meeting. San Francisco, CA. May 7th 2009. P-202 Translation track
  25. Rocio I. Pereira, Brenda Beaty, Miriam Dickinson, Edward P. Havranek, Mori J. Krantz, Carlin S. Long. Adiponectin is lower in Latino vs. non-Latino patients with hypertension. American Endocrine Society meeting 2009.
  26. ASSOCIATION BETWEEN 25-HYDROXYVITAMIN D LEVELS AND INSULIN RESISTANCE IN HYPERTENSIVE SUBJECTS. CCL Wang, RI Pereira, K Benton, M Dickinson, R Estacio, M Krantz, C Neuman, C Long, E Havranek, M Chonchol. 14th annual international conference on Vitamin D. Brugge, Belgium October 2009.
  27. Vitamin D levels and insulin resistance in a mostly Latino hypertensive cohort Cecilia CL Wang, MD*1,2, Rocio I Pereira, MD2,3, Kathryn L Benton, MSPH2,4, L Miriam Dickinson, PhD2,4, Raymond O Estacio, MD2,4, Mori J Krantz, MD2,3, Christine Neuman4, Carlin S Long, MD2,3, Edward Havranek, MD2,3 and Michel B Chonchol, MD2,3. American Society of Neprhology (ASN) meeting 2009.
  28. Cardiovascular Disease is associated with COPD severity and reduced functional capacity. Jennifer Black-Shinn, Gregory L. Kinney, Elizabeth Regan, Barry Make, Mori Krantz, R. Graham Barr, James Murphy, Edward Silverman, James Crapo, John E. Hokanson for the COPDGene Investigators. American Thoracic Society 2010.